APLM
APLM
NASDAQ · Biotechnology

Apollomics Inc

$19.25
+0.65 (+3.49%)
As of Feb 8, 2:24 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.59M 4.05M 3.58M
Net Income -196,564 -196,089 -156,693
EPS
Profit Margin -4.3% -4.8% -4.4%
Rev Growth +16.2% +0.5% -3.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 9.54M 7.54M 8.50M
Total Equity 8.98M 8.14M 8.85M
D/E Ratio 1.06 0.93 0.96
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -265,994 -241,454 -219,779
Free Cash Flow -252,687 -239,821 -142,632